150 related articles for article (PubMed ID: 34565408)
21. Identification of potential crucial genes and molecular mechanisms in glioblastoma multiforme by bioinformatics analysis.
Chen X; Pan Y; Yan M; Bao G; Sun X
Mol Med Rep; 2020 Aug; 22(2):859-869. PubMed ID: 32467990
[TBL] [Abstract][Full Text] [Related]
22. New insights for precision treatment of glioblastoma from analysis of single-cell lncRNA expression.
Meng Q; Zhang Y; Li G; Li Y; Xie H; Chen X
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1881-1895. PubMed ID: 33693962
[TBL] [Abstract][Full Text] [Related]
23. Glioblastoma Molecular Classification Tool Based on mRNA Analysis: From Wet-Lab to Subtype.
Steponaitis G; Kucinskas V; Golubickaite I; Skauminas K; Saudargiene A
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555518
[TBL] [Abstract][Full Text] [Related]
24. Increased LGALS3 expression independently predicts shorter overall survival in patients with the proneural subtype of glioblastoma.
He X; Zhang S; Chen J; Li D
Cancer Med; 2019 May; 8(5):2031-2040. PubMed ID: 30848102
[TBL] [Abstract][Full Text] [Related]
25. Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution.
Li R; Li H; Yan W; Yang P; Bao Z; Zhang C; Jiang T; You Y
Oncotarget; 2015 Mar; 6(9):7318-24. PubMed ID: 25821160
[TBL] [Abstract][Full Text] [Related]
26. Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2.
Bouchart C; Trépant AL; Hein M; Van Gestel D; Demetter P
Cancer Med; 2020 Feb; 9(3):1069-1078. PubMed ID: 31568682
[TBL] [Abstract][Full Text] [Related]
27. An eight-mRNA signature outperforms the lncRNA-based signature in predicting prognosis of patients with glioblastoma.
Gong Z; Hong F; Wang H; Zhang X; Chen J
BMC Med Genet; 2020 Mar; 21(1):56. PubMed ID: 32188434
[TBL] [Abstract][Full Text] [Related]
28. Expression and prognostic significance of TCTN1 in human glioblastoma.
Meng D; Chen Y; Zhao Y; Wang J; Yun D; Yang S; Chen J; Chen H; Lu D
J Transl Med; 2014 Oct; 12():288. PubMed ID: 25304031
[TBL] [Abstract][Full Text] [Related]
29. Molecular subtyping of glioblastoma based on immune-related genes for prognosis.
Chen X; Fan X; Zhao C; Zhao Z; Hu L; Wang D; Wang R; Fang Z
Sci Rep; 2020 Sep; 10(1):15495. PubMed ID: 32968155
[TBL] [Abstract][Full Text] [Related]
30. PARP1 expression and its correlation with survival is tumour molecular subtype dependent in glioblastoma.
Murnyák B; Kouhsari MC; Hershkovitch R; Kálmán B; Marko-Varga G; Klekner Á; Hortobágyi T
Oncotarget; 2017 Jul; 8(28):46348-46362. PubMed ID: 28654422
[TBL] [Abstract][Full Text] [Related]
31. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
Fan F; Zhang H; Dai Z; Zhang Y; Xia Z; Cao H; Yang K; Hu S; Guo Y; Ding F; Cheng Q; Zhang N
Cell Oncol (Dordr); 2021 Aug; 44(4):917-935. PubMed ID: 34142341
[TBL] [Abstract][Full Text] [Related]
32. The analysis of miRNA expression profiling datasets reveals inverse microRNA patterns in glioblastoma and Alzheimer's disease.
Candido S; Lupo G; Pennisi M; Basile MS; Anfuso CD; Petralia MC; Gattuso G; Vivarelli S; Spandidos DA; Libra M; Falzone L
Oncol Rep; 2019 Sep; 42(3):911-922. PubMed ID: 31322245
[TBL] [Abstract][Full Text] [Related]
33. Bioinformatic analyses reveal a distinct Notch activation induced by STAT3 phosphorylation in the mesenchymal subtype of glioblastoma.
Cheng W; Zhang C; Ren X; Jiang Y; Han S; Liu Y; Cai J; Li M; Wang K; Liu Y; Hu H; Li Q; Yang P; Bao Z; Wu A
J Neurosurg; 2017 Jan; 126(1):249-259. PubMed ID: 26967788
[TBL] [Abstract][Full Text] [Related]
34. A robust two-gene signature for glioblastoma survival prediction.
Pan Y; Zhang JH; Zhao L; Guo JC; Wang S; Zhao Y; Tao S; Wang H; Zhu YB
J Cell Biochem; 2020 Jul; 121(7):3593-3605. PubMed ID: 31960992
[TBL] [Abstract][Full Text] [Related]
35. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology.
Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL
Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447
[TBL] [Abstract][Full Text] [Related]
36. Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression.
Murata H; Yoshimoto K; Hatae R; Akagi Y; Mizoguchi M; Hata N; Kuga D; Nakamizo A; Amano T; Sayama T; Iihara K
J Neurooncol; 2015 Oct; 125(1):33-41. PubMed ID: 26272600
[TBL] [Abstract][Full Text] [Related]
37. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
[TBL] [Abstract][Full Text] [Related]
38. A three ion channel genes-based signature predicts prognosis of primary glioblastoma patients and reveals a chemotherapy sensitive subtype.
Wang HY; Li JY; Liu X; Yan XY; Wang W; Wu F; Liang TY; Yang F; Hu HM; Mao HX; Liu YW; Zhang SZ
Oncotarget; 2016 Nov; 7(46):74895-74903. PubMed ID: 27713134
[TBL] [Abstract][Full Text] [Related]
39. Associations between microRNA expression and mesenchymal marker gene expression in glioblastoma.
Ma X; Yoshimoto K; Guan Y; Hata N; Mizoguchi M; Sagata N; Murata H; Kuga D; Amano T; Nakamizo A; Sasaki T
Neuro Oncol; 2012 Sep; 14(9):1153-62. PubMed ID: 22844109
[TBL] [Abstract][Full Text] [Related]
40. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
